Cartesian Therapeutics
RNAC
Insider trades and stock quote 2024-2026
All insider trades at Cartesian Therapeutics
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
1/6/2026
|
Sell |
Davis, Blaine |
Chief Financial Officer |
$6.8 |
$72,227 |
|
1/6/2026
|
Sell |
Miljkovic, Milos |
Chief Medical Officer |
$6.8 |
$24,367 |
|
1/6/2026
|
Sell |
Brunn, Carsten |
President and CEO |
$6.8 |
$162,077 |
|
12/4/2025
|
Buy |
Barabe, Timothy C. |
Director |
$6.9 |
$205,797 |
|
4/11/2025
|
Buy |
Springer, Timothy A. |
Director |
$10.8 |
$460,529 |
|
4/10/2025
|
Buy |
Springer, Timothy A. |
Director |
$10.7 |
$598,524 |
|
4/9/2025
|
Buy |
Springer, Timothy A. |
Director |
$9.7 |
$463,464 |
|
3/20/2025
|
Buy |
Springer, Timothy A. |
Director |
$15.6 |
$855,593 |
|
3/19/2025
|
Buy |
Springer, Timothy A. |
Director |
$15.0 |
$302,962 |
|
3/18/2025
|
Buy |
Springer, Timothy A. |
Director |
$14.4 |
$212,599 |
|
1/14/2025
|
Buy |
Springer, Timothy A. |
Director |
$18.0 |
$72,396 |
|
1/13/2025
|
Buy |
Springer, Timothy A. |
Director |
$17.3 |
$293,958 |
|
1/6/2025
|
Sell |
Davis, Blaine |
Chief Financial Officer |
$16.8 |
$67,800 |
|
1/6/2025
|
Sell |
Brunn, Carsten |
President and CEO |
$16.8 |
$146,575 |
|
1/6/2025
|
Sell |
English, Emily |
Chief Operations Officer |
$16.8 |
$15,250 |
|
1/6/2025
|
Sell |
Jewell, Christopher M. |
Chief Scientific Officer |
$16.8 |
$21,646 |
|
1/6/2025
|
Sell |
Miljkovic, Milos |
Chief Medical Officer |
$16.8 |
$15,957 |
|
1/6/2025
|
Sell |
Kurtoglu, Metin |
Chief Technology Officer |
$16.8 |
$41,374 |
|
1/3/2025
|
Sell |
Davis, Blaine |
Chief Financial Officer |
$16.7 |
$66,235 |
|
1/3/2025
|
Sell |
Brunn, Carsten |
President and CEO |
$16.7 |
$143,190 |
|
1/3/2025
|
Sell |
English, Emily |
Chief Operations Officer |
$16.7 |
$14,899 |
|
1/3/2025
|
Sell |
Jewell, Christopher M. |
Chief Scientific Officer |
$16.7 |
$21,136 |
|
1/3/2025
|
Sell |
Miljkovic, Milos |
Chief Medical Officer |
$16.7 |
$15,585 |
|
1/3/2025
|
Sell |
Kurtoglu, Metin |
Chief Technology Officer |
$16.7 |
$40,417 |
|
12/23/2024
|
Buy |
Springer, Timothy A. |
Director |
$19.0 |
$98,437 |
|
12/20/2024
|
Buy |
Springer, Timothy A. |
Director |
$18.9 |
$412,968 |
|
12/19/2024
|
Buy |
Springer, Timothy A. |
Director |
$18.2 |
$453,616 |
|
12/10/2024
|
Sell |
Kurtoglu, Metin |
Chief Technology Officer |
$24.4 |
$70,640 |
|
12/9/2024
|
Sell |
Kurtoglu, Metin |
Chief Technology Officer |
$25.6 |
$274,493 |
|
11/21/2024
|
Sell |
Kurtoglu, Metin |
Chief Technology Officer |
$16.7 |
$546,560 |
|
11/20/2024
|
Sell |
Kurtoglu, Metin |
Chief Technology Officer |
$17.7 |
$98,570 |
|
11/19/2024
|
Sell |
Kurtoglu, Metin |
Chief Technology Officer |
$19.5 |
$3,900 |
|
11/18/2024
|
Sell |
Kurtoglu, Metin |
Chief Technology Officer |
$18.4 |
$632,641 |
|
11/18/2024
|
Buy |
Springer, Timothy A. |
Director |
$18.2 |
$1,056,183 |
|
11/15/2024
|
Sell |
Jewell, Christopher M. |
Chief Scientific Officer |
$17.1 |
$274,093 |
|
11/15/2024
|
Sell |
Miljkovic, Milos |
Chief Medical Officer |
$17.1 |
$342,888 |
|
11/15/2024
|
Sell |
Kurtoglu, Metin |
Chief Technology Officer |
$17.2 |
$379,497 |
|
11/15/2024
|
Buy |
Springer, Timothy A. |
Director |
$17.1 |
$4,739,188 |
|
11/14/2024
|
Sell |
Jewell, Christopher M. |
Chief Scientific Officer |
$16.7 |
$600,950 |
|
11/14/2024
|
Sell |
Miljkovic, Milos |
Chief Medical Officer |
$16.1 |
$564,645 |
|
11/14/2024
|
Sell |
Kurtoglu, Metin |
Chief Technology Officer |
$16.7 |
$425,901 |
|
11/14/2024
|
Buy |
Springer, Timothy A. |
Director |
$16.6 |
$1,578,156 |
|
10/4/2024
|
Buy |
Springer, Timothy A. |
Director |
$22.8 |
$1,813,009 |
|
10/3/2024
|
Buy |
Springer, Timothy A. |
Director |
$20.1 |
$2,384,713 |
|
10/2/2024
|
Buy |
Springer, Timothy A. |
Director |
$17.4 |
$95,822 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Follow insider buying in real time via push in our Telegram channel.
Join now